CR20210549A - Composición para regeneración de tejidos, método de producción y usos de la misma - Google Patents

Composición para regeneración de tejidos, método de producción y usos de la misma

Info

Publication number
CR20210549A
CR20210549A CR20210549A CR20210549A CR20210549A CR 20210549 A CR20210549 A CR 20210549A CR 20210549 A CR20210549 A CR 20210549A CR 20210549 A CR20210549 A CR 20210549A CR 20210549 A CR20210549 A CR 20210549A
Authority
CR
Costa Rica
Prior art keywords
tissue
compositions
macrophages
treatments
composition
Prior art date
Application number
CR20210549A
Other languages
English (en)
Inventor
Moreno Carmen Iglesias
Fernández Juan Pedro Lapuente
Calvo María Cayuela
Vicente Pablo Fernández
Cepa Gonzalo Gómez
Bielsa Paula Desporte
Anjos Vilaboa Severiano Dos
Gregorio Juan Carlos De
Martínez Alejandro Blázquez
Moreno Jara Sanz
Original Assignee
Peaches S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peaches S L filed Critical Peaches S L
Publication of CR20210549A publication Critical patent/CR20210549A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/99—Serum-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/08—Coculture with; Conditioned medium produced by cells of the nervous system
    • C12N2502/086—Coculture with; Conditioned medium produced by cells of the nervous system glial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C12N2502/1157—Monocytes, macrophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1317—Chondrocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1335—Skeletal muscle cells, myocytes, myoblasts, myotubes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1341—Tenocytes, cells from tendons and ligaments
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1352—Mesenchymal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
    • C12N2506/115—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells from monocytes, from macrophages

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Wood Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La invención describe un método para obtener una composición para regeneración de tejido, que comprende los siguientes pasos: proporcionar macrófagos M2, cocultivar los macrófagos M2 con células específicas de tejido en medio libre de suero; y recolectar el sobrenadante del cocultivo. Las composiciones obtenidas por este método son adecuadas en tratamientos regenerativos medicinales, ya que son capaces de regenerar el tejido lesionado. Estos productos son soluciones acuosas fisiológicas estériles sin células que muestran patrones de concentración de tejido específicos para proporcionar efectos regenerativos específicos de tejido óptimos. Las composiciones de la invención pueden almacenar por periodos prolongados crioconservados o liofilizados hasta su uso, evitando cualquier extracción de sangre subsecuente del donante de células, que son los factores de crecimiento y/o citocinas almacenados biológicamente activas después almacenamiento a largo plazo. Por otra, las composiciones se pueden aplicar potencialmente en tratamientos tanto autólogos como alogénicos.
CR20210549A 2019-04-03 2020-04-02 Composición para regeneración de tejidos, método de producción y usos de la misma CR20210549A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19382247.5A EP3719119A1 (en) 2019-04-03 2019-04-03 Tissue-specific growth factors, method of production and uses thereof
PCT/EP2020/059365 WO2020201404A1 (en) 2019-04-03 2020-04-02 Composition for tissue regeneration, method of production and uses thereof

Publications (1)

Publication Number Publication Date
CR20210549A true CR20210549A (es) 2021-11-30

Family

ID=66240019

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20210549A CR20210549A (es) 2019-04-03 2020-04-02 Composición para regeneración de tejidos, método de producción y usos de la misma

Country Status (19)

Country Link
US (1) US20220169987A1 (es)
EP (2) EP3719119A1 (es)
CN (1) CN113825833A (es)
AU (1) AU2020252248A1 (es)
BR (1) BR112021019745A2 (es)
CA (1) CA3135661A1 (es)
CL (1) CL2021002567A1 (es)
CO (1) CO2021014689A2 (es)
CR (1) CR20210549A (es)
DO (1) DOP2021000207A (es)
EC (1) ECSP21078755A (es)
ES (1) ES2971499T3 (es)
HR (1) HRP20240153T1 (es)
HU (1) HUE065101T2 (es)
MX (1) MX2021012141A (es)
PE (1) PE20220424A1 (es)
PL (1) PL3947648T3 (es)
RS (1) RS65119B1 (es)
WO (1) WO2020201404A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9950035B2 (en) * 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
TWI640631B (zh) * 2017-08-16 2018-11-11 國立屏東科技大學 Macrophage conditioned medium, dressing, preparation method and use thereof for promoting wound healing

Also Published As

Publication number Publication date
EP3947648A1 (en) 2022-02-09
CN113825833A (zh) 2021-12-21
US20220169987A1 (en) 2022-06-02
CL2021002567A1 (es) 2022-06-17
PL3947648T3 (pl) 2024-04-15
HUE065101T2 (hu) 2024-05-28
AU2020252248A1 (en) 2021-11-25
WO2020201404A1 (en) 2020-10-08
DOP2021000207A (es) 2021-11-21
ES2971499T3 (es) 2024-06-05
PE20220424A1 (es) 2022-03-29
RS65119B1 (sr) 2024-02-29
CO2021014689A2 (es) 2021-11-19
EP3947648B1 (en) 2023-11-15
ECSP21078755A (es) 2021-12-30
HRP20240153T1 (hr) 2024-04-26
BR112021019745A2 (pt) 2021-12-21
MX2021012141A (es) 2021-11-03
EP3719119A1 (en) 2020-10-07
EP3947648C0 (en) 2023-11-15
CA3135661A1 (en) 2020-10-08

Similar Documents

Publication Publication Date Title
Leal‐Marin et al. Human Amniotic Membrane: A review on tissue engineering, application, and storage
JP6130588B2 (ja) 皮膚再生または傷治癒のための間葉系幹細胞−ヒドロゲル−生分解性または間葉系幹細胞−ヒドロゲル−非分解性支持体造成物
Rennert et al. Biological therapies for the treatment of cutaneous wounds: phase III and launched therapies
Petrof et al. Cell therapy in dermatology
Grounds Obstacles and challenges for tissue engineering and regenerative medicine: Australian nuances
CN104027794A (zh) 人脐带间充质干细胞复合细胞因子在制备修复皮肤损伤的生物制剂中的应用
AR080221A1 (es) Productos de membranas amnioticas inmunocompatibles
MX2009004238A (es) Metodos y composiciones para tratamiento de defectos oseos con poblaciones de celulas de placenta.
WO2007035843A3 (en) Methods and compositions for organ and tissue functionality
CA2387542A1 (en) Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation
CN102580153A (zh) 一种制备脱细胞真皮基质医用组织补片的方法
CN102670654A (zh) 一种用于创面修复的干细胞制剂及其制备方法
SG11201804755VA (en) Method for manufacturing tissue/organ by using blood cells
US20170368231A1 (en) Bioengineered Regenerative Graft Matrix, and Methods for Making Thereof
WO2004011631A3 (en) Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus
Morimoto et al. An evaluation of the engraftment and the blood flow of porcine skin autografts inactivated by high hydrostatic pressure
CR20210549A (es) Composición para regeneración de tejidos, método de producción y usos de la misma
RU2012135969A (ru) Способ лечения длительно незаживающей раны и/или раневой полости
Khodadadi et al. Cell therapy in burn repair
Soejima et al. Wound dressing material containing lyophilized allogeneic cultured cells
JP2016067711A (ja) 移植用皮膚組織片の作製方法
RU2010122327A (ru) Способ лечения нейротрофических язв конечностей
JP5066699B2 (ja) 粘膜組織由来の線維芽細胞、これを含有する組織改善材及びこれらの製造方法並びに利用方法
Yamada et al. Comparative evaluation of re-epithelialization promoted by fresh or cryopreserved cultured dermal substitute
TW201613621A (en) Composition for promoting growth of dermal papilla cells, pharmaceutical composition, and preparation method thereof